Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND WIF1, WIF-1, 11197, ENSG00000156076
65 results:

  • 1. Methylation study of tumor suppressor genes in human aberrant crypt foci, colorectal carcinomas, and normal colon.
    Sarangi J; Das P; Ahmad A; Sulaiman M; Ghosh S; Gupta B; Panwar R; Pal S; Yadav R; Ahuja V; Sen S; Upadhyay AD; Dash NR; Sharma A; Gupta SD
    J Cancer Res Ther; 2024 Jan; 20(1):268-274. PubMed ID: 38554332
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating DNA in the neoadjuvant setting of early stage colon cancer.
    Bregni G; Pretta A; Senti C; Acedo Reina E; Vandeputte C; Trevisi E; Gkolfakis P; Kehagias P; Deleporte A; Van Laethem JL; Vergauwe P; Van den Eynde M; Deboever G; Janssens J; Demolin G; Holbrechts S; Clausse M; De Grez T; Peeters M; D'Hondt L; Geboes K; Besse-Hammer T; Rothé F; Flamen P; Hendlisz A; Sclafani F
    Acta Oncol; 2022 Oct; 61(10):1223-1229. PubMed ID: 35866544
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The detection of specific hypermethylated wif1 and NPY genes in circulating DNA by crystal digital PCR™ is a powerful new tool for colorectal cancer diagnosis and screening.
    Overs A; Flammang M; Hervouet E; Bermont L; Pretet JL; Christophe B; Selmani Z
    BMC Cancer; 2021 Oct; 21(1):1092. PubMed ID: 34627187
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon cancer: a
    Taieb J; Taly V; Henriques J; Bourreau C; Mineur L; Bennouna J; Desrame J; Louvet C; Lepere C; Mabro M; Egreteau J; Bouche O; Mulot C; Hormigos K; Chaba K; Mazard T; de Gramont A; Vernerey D; André T; Laurent-Puig P
    Clin Cancer Res; 2021 Oct; 27(20):5638-5646. PubMed ID: 34083233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Toward colorectal cancer Biomarkers: The Role of Genetic Variation, Wnt Pathway, and Long Noncoding RNAs.
    Abdel-Motaleb AI; Azzazy HM; Moustafa A
    OMICS; 2021 May; 25(5):302-312. PubMed ID: 33891491
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Methylation patterns in dysplasia in inflammatory bowel disease patients.
    Rosa I; Silva P; da Mata S; Magro F; Carneiro F; Peixoto A; Silva M; Sousa HT; Roseira J; Parra J; Barosa R; Vieira A; Brito MJ; Lago P; Coelho A; Moleiro J; Pereira da Silva J; Fonseca R; Albuquerque C; Dias Pereira A;
    Scand J Gastroenterol; 2020 Jun; 55(6):646-655. PubMed ID: 32456486
    [No Abstract]    [Full Text] [Related]  

  • 7. Candidate genes for hereditary colorectal cancer: Mutational screening and systematic review.
    Belhadj S; Terradas M; Munoz-Torres PM; Aiza G; Navarro M; Capellá G; Valle L
    Hum Mutat; 2020 Sep; 41(9):1563-1576. PubMed ID: 32449991
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effects of propofol on colon cancer metastasis through STAT3/HOTAIR axis by activating wif-1 and suppressing Wnt pathway.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Cancer Med; 2020 Mar; 9(5):1842-1854. PubMed ID: 31953926
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DNA methylation of SFRP1, SFRP2, and wif1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
    Sobhani I; Bergsten E; Couffin S; Amiot A; Nebbad B; Barau C; de'Angelis N; Rabot S; Canoui-Poitrine F; Mestivier D; Pédron T; Khazaie K; Sansonetti PJ
    Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24285-24295. PubMed ID: 31712445
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer.
    Moati E; Blons H; Taly V; Garlan F; Wang-Renault SF; Pietrasz D; Didelot A; Garrigou S; Saint A; Pernot S; Taieb J; Laurent-Puig P; Zaanan A
    Int J Cancer; 2020 Aug; 147(4):1185-1189. PubMed ID: 31472013
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.
    Beggs AD; Mehta S; Deeks JJ; James JD; Caldwell GM; Dilworth MP; Stockton JD; Blakeway D; Pestinger V; Vince A; Taniere P; Iqbal T; Magill L; Matthews G; Morton DG;
    EBioMedicine; 2019 Jan; 39():265-271. PubMed ID: 30473377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of wif-1 in inflammatory bowel disease.
    Terry R; Chintanaboina J; Patel D; Lippert B; Haner M; Price K; Tracy A; Lalos A; Wakeley M; Gutierrez LS
    Histol Histopathol; 2019 Feb; 34(2):149-157. PubMed ID: 30051904
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor Suppressive Role of ARHGAP17 in Colon cancer Through Wnt/β-Catenin Signaling.
    Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
    Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genistein inhibits invasion and migration of colon cancer cells by recovering wif1 expression.
    Zhu J; Ren J; Tang L
    Mol Med Rep; 2018 May; 17(5):7265-7273. PubMed ID: 29568950
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
    Bachet JB; Bouché O; Taieb J; Dubreuil O; Garcia ML; Meurisse A; Normand C; Gornet JM; Artru P; Louafi S; Bonnetain F; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Taly V; Blons H; Vernerey D; Laurent-Puig P
    Ann Oncol; 2018 May; 29(5):1211-1219. PubMed ID: 29438522
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting wif1 and DKK1.
    Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Screening and identification of a tumor specific methylation phenotype in the colorectal laterally spreading tumor.
    Ni HB; Wang FY; Xu J; He XJ; Chen J; Wu Q; Wu JF; Sun YS
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2611-2616. PubMed ID: 28678324
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic colorectal cancer Patients (PLACOL Study).
    Garlan F; Laurent-Puig P; Sefrioui D; Siauve N; Didelot A; Sarafan-Vasseur N; Michel P; Perkins G; Mulot C; Blons H; Taieb J; Di Fiore F; Taly V; Zaanan A
    Clin Cancer Res; 2017 Sep; 23(18):5416-5425. PubMed ID: 28576867
    [No Abstract]    [Full Text] [Related]  

  • 20. Lack of Aberrant Methylation in an Adjacent Area of Left-Sided colorectal cancer.
    Sambuudash O; Kim HS; Cho MY
    Yonsei Med J; 2017 Jul; 58(4):749-755. PubMed ID: 28540987
    [TBL] [Abstract] [Full Text] [Related]  


    of 4.